Prevention of recurrent esophageal bleeding and survival in patients with alcoholic cirrhosis: a randomized study
- PMID: 8994285
Prevention of recurrent esophageal bleeding and survival in patients with alcoholic cirrhosis: a randomized study
Abstract
Objectives: To compare endoscopic sclerotherapy, propranolol and distal splenorenal shunt in the prevention of rebleeding esophageal varices and mortality in alcoholic cirrhotics.
Methods: Forty-three alcoholic cirrhotics that had bled from esophageal varices were randomized to sclerotherapy (13), shunt (15) or propranolol(15). Outcomes measured were rebleeding from varices and death.
Results: There was no significant difference between the three treatment groups in relation to rebleeding rate or death. Continued alcohol consumption did not influence outcome.
Conclusions: All three therapies were equally effective in preventing rebleeding from varices.
Similar articles
-
[Elective-selective Warren splenorenal shunt operation. Prognosis of liver function and esophageal varices hemorrhage after repeat sclerotherapy in liver cirrhosis].Chirurg. 1991 Nov;62(11):794-8; discussion 798-9. Chirurg. 1991. PMID: 1769259 German.
-
Prevention of variceal rebleeding.Gastroenterol Clin North Am. 1992 Mar;21(1):119-47. Gastroenterol Clin North Am. 1992. PMID: 1349003 Review.
-
[Prevention of recurrent hemorrhage in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy].Gastroenterol Clin Biol. 1991;15(11):833-7. Gastroenterol Clin Biol. 1991. PMID: 1769473 Clinical Trial. French.
-
Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions.Acta Chir Scand. 1990 Oct;156(10):711-5. Acta Chir Scand. 1990. PMID: 2264429 Clinical Trial.
-
[Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients].Gastroenterol Clin Biol. 1988 Dec;12(12):899-905. Gastroenterol Clin Biol. 1988. PMID: 3069544 Review. French.
Cited by
-
Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis.Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD000553. doi: 10.1002/14651858.CD000553.pub2. Cochrane Database Syst Rev. 2006. PMID: 17054131 Free PMC article.
-
Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.Cochrane Database Syst Rev. 2020 Oct 22;10(10):CD000553. doi: 10.1002/14651858.CD000553.pub3. Cochrane Database Syst Rev. 2020. PMID: 33089892 Free PMC article.
-
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Mar 30;3(3):CD013122. doi: 10.1002/14651858.CD013122.pub2. Cochrane Database Syst Rev. 2021. PMID: 33784794 Free PMC article.
-
Carvedilol and traditional nonselective beta blockers for the secondary prophylaxis of variceal hemorrhage and portal hypertension related complications among patients with decompensated cirrhosis: a systematic review and network meta-analysis.Hepatol Int. 2025 Jun;19(3):647-661. doi: 10.1007/s12072-025-10812-8. Epub 2025 Apr 3. Hepatol Int. 2025. PMID: 40178720
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical